We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 514

AMA welcomes ACCC legal action against Medibank Private
  • Russell Kennedy
  • Australia
  • July 29 2016

The Australian Medical Association ("AMA") has welcomed the Australian Competition and Consumer Commission's ("ACCC") decision to commence legal


Misuse of market power: How proposed changes to the law will affect the private health insurance sector
  • DLA Piper LLP
  • Australia
  • April 6 2016

The Turnbull Government recently announced that it will adopt the Harper Review's recommendation to amend section 46 of the Competition and Consumer


Australian health sector remains under ACCC spotlight in 2016
  • DLA Piper LLP
  • Australia
  • March 17 2016

The Australian Competition and Consumer Commission (ACCC) recently released its enforcement priorities for 2016. Each year, the ACCC nominates its


Major trends give rise to competition concerns in the Australian life sciences sector
  • DLA Piper LLP
  • Australia
  • December 1 2015

Many of the global challenges encountered by the life sciences sector in recent years have emerged in Australia. Consistent with the global outlook


RK health insights 19 November 2015
  • Russell Kennedy
  • Australia
  • November 19 2015

The Federal Government is set to remove 17 common over-the-counter medicines (including paracetamol and aspirin) from the Pharmaceutical Benefits


Regulating the nip and tuck: cosmetic medical services growth expands
  • Maddocks
  • Australia
  • May 21 2015

Cosmetic medicine is one of Australia's fastest growing consumer markets, yet the AUD $1 billion1 consumer market is largely unregulated. On the


Harper Review dispenses important recommendations for the life sciences sector
  • DLA Piper LLP
  • Australia
  • May 6 2015

The long-awaited Harper Review final report was released on 31 March 2015. This update highlights key recommendations relevant to the life sciences


Food law: quick bites and upcoming calendar
  • King & Wood Mallesons
  • Australia
  • April 30 2015

The ACCC is seeking leave to appeal the Federal Court decision dismissing its case against Pfizer for alleged misuse of market power and exclusive


Traversing the patent cliff
  • DLA Piper LLP
  • Australia
  • April 29 2015

On 25 February 2015, the Federal Court handed down its much-anticipated judgment in the matter of ACCC v Pfizer Australia Pty Ltd. In dismissing the


Harper Review - implications for the private health insurance industry
  • DLA Piper LLP
  • Australia
  • April 10 2015

On 31 March 2015 the final report of the Competition Policy Review Panel chaired by Professor Ian Harper (Harper Review) was released. The Harper